Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost TransparencyPRNewsWire • 10/06/23
Holmusk, Veradigm Announce New Phase of Strategic Investment to Fuel Innovation and Close the Evidence Gap in Behavioral HealthBusiness Wire • 10/02/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Veradigm Inc. (MDRX) on Behalf of InvestorsPRNewsWire • 09/29/23
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Veradigm Inc. (MDRX) on Behalf of InvestorsPRNewsWire • 09/28/23
Veradigm and On Belay Health Solutions Collaborate to Expand Value-Based Care Solutions to More Primary Care PracticesBusiness Wire • 09/28/23
Veradigm Inc. Announces Receipt of Nasdaq Delisting Notice and Intent to AppealBusiness Wire • 09/22/23
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Veradigm Inc.PRNewsWire • 09/08/23
MDRX NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Veradigm Inc.PRNewsWire • 08/01/23
MDRX ALERT: The Law Offices of Vincent Wong Investigate Veradigm Inc. for Potential Violations of Securities LawsPRNewsWire • 07/31/23
MDRX FRAUD ALERT: Jakubowitz Law is Investigating Veradigm Inc. in Connection with Potential Violations of Federal Securities LawsPRNewsWire • 07/28/23
Veradigm Inc. Receives Approval from Nasdaq of Plan to Regain Listing ComplianceBusiness Wire • 06/13/23
Veradigm Payerpath™ Rated #1 End-to-End Revenue Cycle Management (RCM) SoftwareBusiness Wire • 06/08/23
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Veradigm Inc. Investors to Inquire About Class Action Investigation - MDRXPRNewsWire • 03/30/23
Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing, Provides Update on 4th Quarter and Full Fiscal Year 2022 Reporting of ResultsBusiness Wire • 03/22/23